Kcnma1 as a Therapeutic Target in Cancer Treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 20, 2007
app pub date -
May 5, 2004
filing date -
May 6, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention pertains to a treatment of cancer, particularly prostate cancer, by blocking the large conductance, Ca.sup.2+-activated potassium channel KCNMA1 Embodiments of the invention include methods of detecting the level of expression of KCNMA1, methods for treating patients with prostate cancer, and methods of discovering drugs for treating cancer.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully